Wells Fargo lowered the firm’s price target on Scotts Miracle-Gro (SMG) to $85 from $95 and keeps an Overweight rating on the shares. The firm notes Scotts Miracle-Gro had little room for error after surging year-to-date and needed to avoid Q4 noise and guide debates. It avoided neither and Wells gets the pullback. It is unclear if the stock does much into year-end but maybe a tactical long into the season on reset profit, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro price target lowered to $80 from $85 at JPMorgan
- Scotts Miracle-Gro Reports Strong Fiscal 2024 Results
- Scotts Miracle-Gro calls 2025 EBITDA guidance ‘conservative’
- Scotts Miracle-Gro sees 2025 EBITDA of $570M-$590M
- Scotts Miracle-Gro reports Q4 adjusted EPS ($2.31), consensus ($1.97)